Wikipedia -WSS

Wikipedia

author：entertainment 2025-08-11 16:24:57 - browse：4495

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Medicare has officially expanded its coverage policy for brain scans that detect a brain plaque associated with Alzheimer’s disease, the agency announced on Friday.

Amyloid PET scans are important tools to help determine whether patients with mild cognitive impairment are good candidates for new Alzheimer’s drugs, including Eisai and Biogen’s drug Leqembi, which means there will likely be an increase in demand for the scans as uptake increases.

Previously, Medicare limited coverage for the drug to patients enrolled in clinical studies, and only covered one scan in a patient’s lifetime. The new coverage policy removes those restrictions and delegates decisions about how many scans to cover to regional Medicare administrators.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： ACIP vaccine advisory panel sees its vacancies filled

WSS

More doctors should go into startup world

Long Covid research funding gets a major boost from NIH

Tome Biosciences co

Why don't Americans have at

FDA approves Recor Medical high blood pressure device

Report cites 'urgent' need to recruit more diverse clinical trial participants

knowledge

Wikipedia

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Latigo launches with $135 million for Vertex

Continuity nursing helped my family in our darkest PICU moments

Why Eli Lilly’s earnings didn’t quite live up to the hype

State Dept. review finds Biden bears some blame for Afghanistan failures

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Alkermes shareholders re

Medicare will require more price transparency from hospitals

Tori Bowie and the unacceptable rates of Black maternal death

Eli Lilly reports tirzepatide MASH success during Q4 earnings

entertainment

STAT Boddities: What happens to the brain when we get scared?

FDA approves Recor Medical high blood pressure device

White House calls on federal agencies to crack down on AI abuses

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

STAT Executive Editor Rick Berke on STAT's 8th birthday

10 million people disenrolled from Medicaid over past six months

focus

focus

hotspot

focus